January 5 2022
Learn how we are predicting antimicrobial susceptibility directly from blood using whole-genome sequencing with Day Zero Diagnostic's Scientific Co-founder, Melis Anahtar, MD, Phd.
January 4 2022
Day Zero Diagnostics was featured in AACC's December issue of "Clinical Laboratory News", highlighting our work around whole genome sequencing and machine learning for rapid diagnosis of infections directly from blood.
September 29 2021
Day Zero is proud to have been selected for the Disruptive Technology Award from AACC
July 19 2021
Proud to be listed as top Boston startups to follow in 2021 by Startup Stash
December 16 2020
Day Zero is honored to be included in this group of innovative companies disrupting traditional lab testing
December 15 2020
DZD lands a spot on BostInno's 21 startups to watch for in 2021